Leukemia
6 competing products in clinical development for Leukemia.
Pipeline by Phase
Phase 13
Phase 1/21
Phase 21
Phase 31
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Quizartinib + Placebo + Chemotherapy | Daiichi Sankyo | Phase 3 | Recruiting | 47 |
| E7070 + Idarubicin + Cytarabine + Dexamethasone | Eisai | Phase 2 | Completed | 35 |
| Decitabine + Valproic acid | Eisai | Phase 1/2 | Completed | 32 |
| exatecan mesylate | Daiichi Sankyo | Phase 1 | Completed | 29 |
| Decitabine (Dacogen) | Eisai | Phase 1 | Completed | 29 |
| E5564 | Eisai | Phase 1 | Terminated | 21 |